Bristol-Myers Squibb (BMY) Fails to deliver data

Key failure to deliver metrics for Bristol-Myers Squibb:

• Last SEC data release: 2025-02-14
• Last 15 days FTD volume: NZ$0.04 M
• Last 3 months FTD volume: NZ$0.16 B
• Last year FTD volume: NZ$0.16 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Bristol-Myers Squibb (BMY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Bristol-Myers Squibb (BMY) - since 2013

Bristol-Myers Squibb (BMY) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	NZ$24.22 M	NZ$0.33 B	🇺🇸 USA
Merck MRK	NZ$80.49 M	NZ$0.13 B	🇺🇸 USA
Eli Lilly LLY	NZ$98.85 M	NZ$0.23 B	🇺🇸 USA
Novartis NVS	NZ$54.67 M	NZ$0.13 B	🇨🇭 Switzerland
Sanofi SNY	NZ$1.21 M	NZ$47.51 M	🇫🇷 France
AstraZeneca AZN	NZ$38.6 M	NZ$0.18 B	🇬🇧 UK
Johnson & Johnson JNJ	NZ$15.09 M	NZ$0.22 B	🇺🇸 USA
AbbVie ABBV	NZ$43.04 M	NZ$0.20 B	🇺🇸 USA
Amgen AMGN	NZ$37.38 M	NZ$0.21 B	🇺🇸 USA
Biogen BIIB	NZ$42.57 M	NZ$88.22 M	🇺🇸 USA